Stock Chart

BMY

$60.65 -1.33%
Score: 54.3 HOLD
LEAPs: SELL $60
i
LEAPs Option Signal

Type: SELL growth_1yr
Strike: $60
Premium: $9.40
Expiry: Sep 17, 2027
Target: $61
Score: -88

LEAPs are long-term options (1+ year) with less time decay.
Pro
Screener
Vol: 0.31x (vs SPY: 0.5x | vs QQQ: 0.4x)
Volume Ratio Explained

Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech

Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity

Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Chart Pattern · as of Oct 02, 2026
Falling Wedge Bullish scenario quality 66/100
Measured-move target $62.09 (+2.3%) · apex ~19 bars ahead
Historically breaks up 63% of the time; target hit in 75% of up-breaks (n=385)
Pattern detection is automated and probabilistic — a scenario map for levels, not a buy/sell signal. Rails, projected path and target are drawn on the chart below.
Technical Chart
OVERLAYS
INDICATORS
TRENDLINES
OPTIONS FLOW
VOLUME & PRICE
OTHER
SETTINGS
Active (2)
CHART OVERLAYS
Active: 2
INDICATORS
TRENDLINES
OPTIONS FLOW
VOLUME & PRICE
OTHER

About BMY - Bristol-Myers Squibb Co.

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.

Key Statistics

Market Cap $127B
P/E Ratio 13.74
Dividend Yield 0.04%

More BMY Analysis

Buy or Sell Analysis Price Prediction AI Analysis Fair Price Options Advisor Trendline Analysis

This BMY stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track BMY's price movements with trendlines, gamma walls, and key support/resistance levels.